Profile data is unavailable for this security.
About the company
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is a China-based company mainly engaged in research and development, manufacturing and marketing of biomedicine. The Company's products include aminolevulinic acid hydrochloride topical powder (trade name: ALA) and hemporfin or injection (trade name: FuMeiDa), and doxorubicin hydrochloride liposome injection (trade name: LIBOd), among others. Its products are mainly used for skin venereal disease treatment and anti-tumor treatment. The Company conducts its businesses in the domestic market.
- Revenue in CNY (TTM)809.23m
- Net income in CNY102.19m
- Incorporated1996
- Employees948.00
- LocationShanghai Fudan-Zhangjiang Bio-Pharmaceutical Co LtdZhangjiang Hi-tech ParkNo.308 Cailun RoadPudong District, Zhangjiang Hi-tech ParkSHANGHAI 201210ChinaCHN
- Phone+86 2 158553583
- Fax+86 2 158553893
- Websitehttp://www.fd-zj.com
More ▼
0.07%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| E Fund Management Co., Ltd.as of 30 Jun 2023 | 272.31k | 0.04% |
| Guotai Asset Management Co., Ltd.as of 30 Jun 2023 | 87.11k | 0.01% |
| Hongde Fund Management Co., Ltd.as of 30 Jun 2023 | 56.80k | 0.01% |
| Dimensional Fund Advisors Ltd.as of 29 Feb 2024 | 34.10k | 0.01% |
| GF Fund Management Co., Ltd.as of 30 Jun 2022 | 6.79k | 0.00% |
| SSgA Funds Management, Inc.as of 04 Apr 2024 | 4.21k | 0.00% |
| Everbright Securities Asset Management Co., Ltd.as of 30 Jun 2023 | 2.30k | 0.00% |
| Orient Fund Management Co., Ltd.as of 30 Jun 2023 | 2.05k | 0.00% |
| Yinhua Fund Management Co., Ltd.as of 30 Jun 2023 | 1.50k | 0.00% |
| UBS SDIC Fund Management Co., Ltd.as of 30 Jun 2023 | 0.00 | 0.00% |
More ▼
Data from 30 Jun 2023 - 09 May 2024Source: FactSet Research Systems Inc.
